Icon

SYFOVRE (NDA217171)- (15MG/0.1ML (15MG/0.1ML))

PEGCETACOPLAN APELLIS PHARMS
15MG/0.1ML (15MG/0.1ML)
No No
2037-Feb-22 2026-May-14
None 2026-Feb-22
None No
SYFOVRE is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
0 0 0
Total Other Developers None
Drugs with Suitability No
15MG/0.1ML (15MG/0.1ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.